Home > Income Statement > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Consolidated Net Profit

    Back to Income Statement
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹-18 Cr₹-391 Cr₹-800 Cr₹-231 Cr₹-231 Cr

What is the latest Consolidated Net Profit of ONESOURCE SPECIALTY PHARMA ?

The latest Consolidated Net Profit ratio of ONESOURCE SPECIALTY PHARMA is ₹-18 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹-18 Cr
Mar2025₹-391 Cr
Mar2024₹-800 Cr
Mar2023₹-231 Cr
Mar2022₹-231 Cr

How is Consolidated Net Profit of ONESOURCE SPECIALTY PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹-18 Cr
Negative
Mar2025 ₹-391 Cr
Negative
Mar2024 ₹-800 Cr
Negative
Mar2023 ₹-231 Cr
Negative
Mar2022 ₹-231 Cr -

Compare Consolidated Net Profit of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹18,556.7 Cr 4.2% 10.5% -14.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

4.2%

10.5%

-14.7%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses